Alexey Teteryuk – head of direction of foreign economic support of BIOCAD, responsible for establishing contacts with foreign regulatory authorities and support export projects of the company.
BIOCAD is one of the forerunners within the Russian pharmaceutical industry. It's portfolio includes biological and chemical medicines and original products, particularly for the treatment of cancers and autoimmune diseases. The company has grown rapidly, and it has offices in Finland, USA, Brazil, China, India, Vietnam, Egypt and other countries. It exports to Latin America, Middle East, and South-East Asia and is planning to enter the EU markets in the future.